Enhancing Quality of Life in Multiple Myeloma: The Role of Lifestyle Interventions

Multiple myeloma (MM) is the second most common hematological malignancy [...]

Patients with multiple myeloma (MM) face a high risk of [...]

Multiple myeloma (MM) has seen significant treatment advancements, including immune [...]

Multiple myeloma (MM) is a hematologic malignancy that impacts plasma [...]

Researchers of this pilot study assessed the impact of a [...]

High-risk multiple myeloma (MM) is a challenging condition to diagnose [...]

Multiple myeloma is a plasma cell cancer that often develops [...]

Patients newly diagnosed with multiple myeloma (MM) often present with [...]

Multiple myeloma (MM) during pregnancy is rare, with only 45 [...]

Despite significant advancements in multiple myeloma (MM) treatment, high-risk (HR) [...]

In a recently published study, researchers revealed that NSD2 overexpression [...]

This article reviews the role of minimal residual disease (MRD) [...]

Preexisting plasma cell disorders, such as monoclonal gammopathy of undetermined [...]

Lenalidomide (Len) is a crucial treatment for multiple myeloma (MM), [...]

Authors of this article discuss the role of frailty assessments [...]

Researchers of this pilot study assessed the impact of a [...]

High-risk multiple myeloma (MM) is a challenging condition to diagnose [...]

This study aimed to develop a multiparametric flow cytometry-based minimal [...]

This study evaluated the performance of mass spectrometry (MS), serum [...]

Researchers of this study analyzed the impact of removing 24-hour [...]

In a recently published study, researchers revealed that NSD2 overexpression [...]

Patients with newly diagnosed multiple myeloma (NDMM) exhibit varying outcomes, [...]

CAR-T therapy has been effective in treating relapsed/refractory hematologic cancers [...]

Measurable residual disease (MRD) status is a critical prognostic indicator [...]

Multiple myeloma (MM) during pregnancy is rare, with only [...]

In a recently published study, researchers revealed that NSD2 [...]

Multiple myeloma (MM) is a cancer of clonal plasma [...]

Measurable residual disease (MRD) status is a critical prognostic [...]

Multiple myeloma (MM) is a malignant clonal plasma cell disorder [...]

Dietary interventions, particularly those impacting the gut microbiome, are shown [...]

A study revealed that caregivers of patients with multiple myeloma [...]

A study assessed treatments for myeloma, noting advancements in patient [...]

Patients with newly diagnosed multiple myeloma (NDMM) exhibit varying outcomes, [...]

A recent study found that cytomegalovirus (CMV) reactivation is a [...]

Researchers of a recent study aimed to evaluate the [...]

The MASTER study (NCT03224507) and GRIFFIN study (NCT02874742) evaluated the [...]

Bispecific antibodies, a novel immunotherapy for multiple myeloma, create immune [...]

The approval of chimeric antigen receptor T-cell (CAR-T) therapies [...]

A study assessed treatments for myeloma, noting advancements in [...]

The FDA Oncologic Drugs Advisory Committee (ODAC) voted 8 [...]

A retrospective cohort study analyzed patients with multiple myeloma (MM) [...]

In patients with multiple myeloma, infection is the primary cause [...]

Researchers investigated arterial thromboembolism (ATE) in patients with multiple [...]

A study explored the use and efficacy of integrative [...]

Plasma cell dyscrasias (PCDs), like multiple myeloma, are hematologic [...]

Currently, multiple targeted therapies are available to treat patients augmenting [...]

Multiple myeloma (MM) survival continues to improve, but population-level data [...]

Researchers analyzed how healthcare disparities in diverse groups affect multiple [...]

A symposium led by four expert nurses – “New and [...]

An informational website by the International Myeloma Foundation medical and [...]

A study explored patients with multiple relapsed or refractory multiple [...]

At the International Myeloma Society Annual Meeting, Beth Faiman, a [...]

Researchers analyzed how healthcare disparities in diverse groups affect multiple [...]